Status:
NOT_YET_RECRUITING
SSSI Efficacy With iACB and PC-LIA in TKA Pain Management
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Postoperative Pain Management in Total Knee Arthroplasty
Peripheral Nerve Blocks
Eligibility:
All Genders
45-90 years
Phase:
NA
Brief Summary
This prospective, triple-blinded, sham-controlled randomized trial evaluates the additive effect of Supra-Sartorial Subcutaneous Infiltration (SSSI) combined with intermittent adductor canal block (iA...
Detailed Description
This prospective, two-armed, triple-blinded, sham-controlled randomized controlled trial investigates the additive effect of Supra-Sartorial Subcutaneous Infiltration (SSSI) to intermittent adductor c...
Eligibility Criteria
Inclusion
- Adults aged 45-90 undergoing unilateral primary TKA for osteoarthritis.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Able to provide informed consent and use NRS pain scales.
- Surgery scheduled to start before noon to standardize spinal anesthesia recovery.
Exclusion
- Bilateral or revision TKA.
- Contraindications to regional anesthesia (e.g., coagulopathy, infection at injection site).
- Chronic opioid use (\>30 mg morphine equivalents/day) or preoperative NRS \>4.
- Pre-existing neurological deficits in lower extremities or AFCN-related neuropathy.
- Allergy to ropivacaine.
- Pregnancy, breastfeeding, or cognitive impairment affecting assessments.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07191964
Start Date
January 1 2026
End Date
February 1 2027
Last Update
October 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.